Kris Elverum
Chief Executive Officer presso Airna, Inc.
Provenienza dei contatti di primo grado di Kris Elverum
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Private Company | Biotechnology | 13 | |
Airna, Inc.
 Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Airna, Inc. is an American company that focuses on the discovery and development of RNA editing therapeutics. Airna was founded by Thorsten Stafforst, Jin Billy Li, Tobias Merkle, Paul Vogel. The CEO is Kris Elverum.
9
| Holding Company | Miscellaneous Commercial Services | 9 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Kris Elverum tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ROCHE HOLDING AG | Pharmaceuticals: Major | Public Communications Contact | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SV Health Investors LLP
 SV Health Investors LLP Investment ManagersFinance SV Health Investors LLP (SV Health Investors) is an Independent Venture Capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Founder Private Equity Investor | |
| RADIUS HEALTH, INC. | Biotechnology | Director of Finance/CFO Investor Relations Contact | |
| SYNCONA LIMITED | Investment Trusts/Mutual Funds | Chief Executive Officer | |
| BAXALTA INC | Biotechnology | Corporate Officer/Principal | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Masters Business Admin Doctorate Degree | |
| MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| The University of Chicago | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| Temple University (Pennsylvania) | College/University | Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree | |
| AVACTA GROUP PLC | Miscellaneous Commercial Services | Director/Board Member | |
| King's College London | College/University | Graduate Degree | |
LS Dissolution, Inc.
 LS Dissolution, Inc. Chemicals: Major DiversifiedProcess Industries LS Dissolution, Inc. engages in the production of petroleum replacement products and industrial chemicals. It offers chemical and fuel products. The company was founded by George M. Church, Christopher Somerville, Noubar B. Afeyan and Jay D. Keasling in 2005 and is headquartered in South San Francisco, CA. | Chemicals: Major Diversified | Corporate Officer/Principal | |
| Universidad Técnica Federico Santa María | College/University | Undergraduate Degree | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
Cxloyalty Inernational Ltd.
 Cxloyalty Inernational Ltd. Miscellaneous Commercial ServicesCommercial Services Cxloyalty Inernational Ltd. provides marketing services to financial institutions and insurance companies. It offers sentinel card protection, a software protection, fraud insurance product for personal computer users, protection, insurance, travel, leisure products and services. The company was founded in 1971 and is headquartered in Slough, the United Kingdom. | Miscellaneous Commercial Services | General Counsel | |
| UNIQURE N.V. | Biotechnology | General Counsel | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Director of Finance/CFO | |
| Columbia Business School | College/University | Masters Business Admin | |
| INNOCOLL HOLDINGS PLC | Pharmaceuticals: Major | Director of Finance/CFO | |
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chief Executive Officer | |
| SYNLOGIC, INC. | Biotechnology | General Counsel | |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chief Executive Officer | |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
| GALECTO, INC. | Pharmaceuticals: Major | Director/Board Member | |
Cellinta Ltd.
 Cellinta Ltd. Investment ManagersFinance Cellinta Ltd. operates as a biotechnology firm. The company was founded on August 16, 2019 and is headquartered in Reading, the United Kingdom. | Investment Managers | Director/Board Member | |
Catamaran Bio, Inc.
 Catamaran Bio, Inc. Financial ConglomeratesFinance Catamaran Bio, Inc. provides investment services. The company is headquartered in Delaware. | Financial Conglomerates | Chief Operating Officer Corporate Officer/Principal | |
| Frankel Group LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Chief Tech/Sci/R&D Officer | |
Cytoimmune Therapeutics, Inc.
 Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 31 |
| Regno Unito | 10 |
| Svizzera | 4 |
| Danimarca | 3 |
| Irlanda | 3 |
Settori
| Health Technology | 25 |
| Consumer Services | 12 |
| Finance | 7 |
| Commercial Services | 4 |
| Process Industries | 3 |
Posizioni
| Director/Board Member | 65 |
| Corporate Officer/Principal | 42 |
| Undergraduate Degree | 13 |
| General Counsel | 11 |
| Private Equity Investor | 10 |
Contatti più connessi
| Insiders | |
|---|---|
| Keith Crandell | 43 |
| Anne Prener | 14 |
| Mark F. Boshar | 13 |
| Rodger Novak | 12 |
| Eric Moessinger | 12 |
| Andrew Oh | 12 |
| Devyn Smith | 10 |
| Laurence Turka | 10 |
| Jose Carmona | 10 |
| Nathan Dowden | 9 |
| Maiken Keson-Brookes | 8 |
| Sean Kendall | 7 |
| Christina Coughlin | 7 |
| Elhan Webb | 6 |
| Christopher L. Carpenter | 6 |
- Borsa valori
- Insiders
- Kris Elverum
- Connessioni Società
